AstraZeneca Vaccine Sales Jump to $894 Mln, Submission for U.S. Approval Delayed ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'AstraZeneca vaccine sales jump to $894 mln, submission for U.S. approval delayed ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)